13 Jul 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

FluoGuide awarded post doc grant to expand the pipeline


October 26, 2020

Copenhagen, Denmark, 26 October 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) is pleased to announce that Innovation Fund Denmark has awarded FluoGuide DKK 1.2 million to a 3-year post doc position for Karina Juhl to explore a complementary class of products to guide oncology surgery.

Karina Juhl has been participating in the preclinical experiments supporting development of FG001 for guiding surgery of glioblastoma. Following her academic PhD position, she will  now join FluoGuide as a post doc researcher in a collaboration with University of Copenhagen. Innovation Fund Denmark has in this relation awarded support of  DKK 1.2 million.

“I am always pleased to see that talented people from my group are being recognized for excellent research that is turned into technologies and products that can help patients fighting cancer”, says Professor Andreas Kjær, CSO in FluoGuide.

FluoGuide A/S is obliged to publish this information in accordance with the EU Market Abuse Regulation. The information was provided by the contact person set out above for publication on 26 October 2020.